Automated quantification of small vessel disease brain changes on MRI predicts cognitive and functional decline

Hanna Jokinen, Juha Koikkalainen, Hanna M. Laakso, Susanna Melkas, Tuomas Nieminen, Antti Brander, Antti Korvenoja, Daniel Rueckert, Frederik Barkhof, Philip Scheltens, Reinhold Schmidt, Franz Fazekas, Sofia Madureira, Ana Verdelho, Anders Wallin, Lars‐Olof Wahlund, Gunhild Waldemar, Hugues Chabriat, Michael G. Hennerici, John T. O’Brien, Domenico Inzitari, Jyrki Lötjönen, Leonardo Pantoni, Timo ErkinjunttibioRxiv 2019 · DOI

TL;DR

This paper introduces an automated MRI analysis pipeline to quantify various brain changes associated with small vessel disease (SVD). They found that a combined measure of these SVD markers, particularly white matter hyperintensities, lacunes, grey matter volume, and hippocampal volume, is a powerful predictor of long-term cognitive and functional decline.

What Problem Does This Paper Address?

Small vessel disease (SVD) is a major contributor to stroke and vascular cognitive impairment, characterized by a range of brain abnormalities like white matter hyperintensities (WMH), lacunes, and infarcts. Accurately quantifying these changes is crucial for understanding their impact on cognitive function and predicting future decline. Traditional methods often rely on visual scoring, which can be subjective and less sensitive to subtle changes. This study aims to address this by developing and validating an automated MRI segmentation approach to precisely measure these SVD markers and assess their predictive power for cognitive and functional outcomes.

Methods

The researchers employed a sophisticated automated image analysis strategy. This involved:

  • Multi-atlas segmentation: For structural segmentation of brain regions, they used a multi-atlas approach, registering multiple atlases to the target image and then applying an Expectation Maximization algorithm for final segmentation.
  • Convolutional Neural Network (CNN) segmentation: For specific SVD features, they utilized U-shaped CNNs. This included segmenting WMH and lacunes using T1, T2, and FLAIR MRI data, and infarcts and enlarged perivascular spaces (EPVS) using T1 and FLAIR data.
  • Postprocessing: After initial segmentation, specific checks were performed for lacunes (intensity, location, size), infarcts (intensity, location, size, asymmetry), and EPVS (region growing, location check).
  • Volumetric Measurement: Volumes of brain structures and SVD lesions were measured using an automated image quantification tool and normalized for head size.

This approach aimed to provide more precise and reproducible volumetric measures compared to visual scoring.

Datasets

The study utilized data from the Leukoaraiosis and Disability (LADIS) Study. This was a longitudinal, multicenter study involving 560 subjects aged 65-84 years, who had mild to severe WMH on MRI but were free of dementia and only minimally impaired in daily living at baseline. The subjects were followed up with annual neuropsychological examinations for 3 years and instrumental activities of daily living (IADL) assessments for 7 years. The paper does not introduce a new benchmark dataset.

Key Insights and Ideas

  • Synergy of SVD markers: The most significant insight is that a combined measure of SVD-related brain changes is a much stronger predictor of cognitive and functional decline than any single marker alone. This highlights the complex, multifactorial nature of SVD's impact.
  • WMH, Lacunes, GM, and Hippocampi are Key: White matter hyperintensities (WMH), lacunes, overall grey matter (GM) volume, and hippocampal volume emerged as the most critical predictors. This suggests that not only white matter lesions but also grey matter integrity and specific structures like the hippocampus are crucial in SVD's progression.
  • Automated Quantification's Power: The study demonstrates the effectiveness of automated MRI segmentation in providing accurate and sensitive measures of SVD, surpassing the limitations of traditional visual scoring methods.
  • Predicting Long-Term Decline: The findings underscore the ability of these automated SVD measures to predict not just short-term cognitive changes but also long-term functional disability and even mortality over a 7-year period.

Key Results

  • Strongest Predictors: Total volumes of WMH, grey matter (GM), and hippocampi were the strongest predictors of global cognitive function, processing speed, executive functions, and memory.
  • Combined Measure Efficacy: A combined SVD score, derived from the z-scores of WMH, lacunes, GM, and hippocampal volumes, significantly predicted both cognitive and functional outcomes (p<0.001), outperforming individual measures.
  • Functional Outcome Prediction: In a multivariable model, WMH, lacunar, and hippocampal volumes remained independent predictors of poor functional outcome. The combined SVD score was also highly predictive of functional outcome (HR=2.7, 95% CI 2.2-3.3, p<0.001).
  • Lacunes, Infarcts, and EPVS: While lacunes showed significant associations with some outcomes, their contribution was generally weaker than WMH, GM, and hippocampi. Cortical infarcts and EPVS had relatively weak predictive value.

Limitations and Future Work

  • Cerebral Microbleeds: The study could not include cerebral microbleeds in the analysis due to the unavailability of susceptibility-weighted MRI sequences. These are considered typical SVD features and risk factors for cognitive dysfunction.
  • Attrition Bias: A potential limitation is attrition bias in follow-up neuropsychological data, where subjects with more severe decline might be more likely to drop out.
  • Sample Characteristics: The LADIS sample was recruited based on age-related WMH, which might have led to a relatively small number of cases with cortical infarcts.
  • Future Directions: The authors suggest that the combined measure of SVD-related brain changes could serve as a valuable neuroimaging metric for vascular cognitive impairment and be beneficial for SVD intervention studies, potentially acting as a more valid surrogate than single MRI findings. They also highlight the need for robust automated methods to characterize diverse SVD pathologies.

Summary updated

Abstract

ABSTRACT Background and purpose Cerebral small vessel disease (SVD) is characterized by a wide range of focal and global brain changes. We used automated MRI segmentation to quantify multiple types of SVD brain changes and examined their individual and combined predictive value on cognitive and functional abilities. Methods MRI scans of 560 subjects of the Leukoaraiosis and Disability Study (LADIS) were analyzed using automated atlas- and convolutional neural network-based segmentation methods yielding volumetric measures of white matter hyperintensities (WMH), lacunes, cortical infarcts, enlarged perivascular spaces and regional brain atrophy. The subjects were followed up with annual neuropsychological examinations for 3 years and evaluation of instrumental activities of daily living for 7 years. Results The strongest predictors of cognitive performance and functional outcome over time were total volumes of WMH, grey matter (GM) and hippocampi (p&lt;0.001 for global cognitive function, processing speed, executive functions and memory; and p&lt;0.001 for poor functional outcome). Volumes of lacunes, cortical infarcts and EVPS were significantly associated with part of the outcome measures, but their contribution was weaker. In a multivariable linear mixed model, volumes of WMH, lacunes, GM and hippocampi remained as independent predictors of cognitive impairment. A combined measure of these markers based on z-scores strongly predicted cognitive and functional outcomes (p&lt;0.001) even above the contribution of the individual brain changes. Conclusions Global burden of SVD-related brain changes as quantified by automated image segmentation is a powerful predictor of long-term cognitive decline and functional disability. A combined measure of WMH, lacunar, GM and hippocampal volumes could be used as an imaging identification model of vascular cognitive impairment.
BibTeX
@misc{jokinen2019automated,
  author = {Hanna Jokinen and Juha Koikkalainen and Hanna M. Laakso and Susanna Melkas and Tuomas Nieminen and Antti Brander and Antti Korvenoja and Daniel Rueckert and Frederik Barkhof and Philip Scheltens and Reinhold Schmidt and Franz Fazekas and Sofia Madureira and Ana Verdelho and Anders Wallin and Lars‐Olof Wahlund and Gunhild Waldemar and Hugues Chabriat and Michael G. Hennerici and John T. O’Brien and Domenico Inzitari and Jyrki Lötjönen and Leonardo Pantoni and Timo Erkinjuntti},
  title = {{Automated quantification of small vessel disease brain changes on MRI predicts cognitive and functional decline}},
  year = {2019},
  doi = {10.1101/621888},
  howpublished = {bioRxiv},
}
Figure